FOXO3a	O
elicits	O
a	O
pro	O
-	O
apoptotic	O
transcription	O
program	O
and	O
cellular	B-Cell
response	O
to	O
human	O
lung	B-Organ
carcinogen	O
nicotine	O
-	O
derived	O
nitrosaminoketone	O
(	O
NNK	O
)	O
.	O

Long	O
-	O
term	O
carcinogen	O
exposure	O
exerts	O
continuous	O
pressure	O
on	O
key	O
mechanisms	O
that	O
repair	O
or	O
eliminate	O
carcinogen	O
-	O
damaged	O
cells	B-Cell
giving	O
rise	O
to	O
selective	O
failures	O
that	O
contribute	O
to	O
lung	B-Cancer
cancer	I-Cancer
.	O

FOXO3a	O
is	O
a	O
transcription	O
factor	O
that	O
elicits	O
a	O
protective	O
response	O
to	O
diverse	O
cellular	B-Cell
stresses	O
.	O

Although	O
implicated	O
as	O
a	O
tumor	B-Cancer
suppressor	O
,	O
its	O
role	O
in	O
sporadic	B-Cancer
cancer	I-Cancer
is	O
uncertain	O
.	O

We	O
recently	O
observed	O
that	O
FOXO3a	O
gene	O
inactivation	O
occurs	O
frequently	O
in	O
carcinogen	O
-	O
induced	O
lung	B-Cancer
adenocarcinoma	I-Cancer
(	O
LAC	B-Cancer
)	O
.	O

This	O
suggests	O
that	O
FOXO3a	O
may	O
play	O
a	O
role	O
in	O
LAC	B-Cancer
suppression	O
by	O
eliciting	O
a	O
protective	O
response	O
to	O
carcinogenic	O
stress	O
.	O

Here	O
we	O
investigated	O
this	O
possibility	O
by	O
examining	O
the	O
role	O
of	O
FOXO3a	O
in	O
the	O
cellular	B-Cell
response	O
to	O
nicotine	O
-	O
derived	O
nitrosaminoketone	O
(	O
NNK	O
)	O
,	O
a	O
lung	B-Organ
carcinogen	O
implicated	O
as	O
a	O
cause	O
of	O
human	O
LAC	B-Cancer
.	O

We	O
show	O
that	O
restoration	O
of	O
FOXO3a	O
in	O
FOXO3a	O
-	O
deficient	O
LAC	B-Cell
cells	I-Cell
increases	O
sensitivity	O
to	O
apoptosis	O
caused	O
by	O
a	O
DNA	O
-	O
damaging	O
intermediate	O
of	O
NNK	O
.	O

Prior	O
to	O
this	O
cellular	B-Cell
outcome	O
,	O
FOXO3a	O
is	O
functionally	O
activated	O
and	O
mediates	O
a	O
large	O
-	O
scale	O
transcription	O
program	O
in	O
response	O
to	O
this	O
damage	O
involving	O
a	O
significant	O
modulation	O
of	O
440	O
genes	O
.	O

Genes	O
most	O
significantly	O
represented	O
in	O
this	O
program	O
are	O
those	O
with	O
roles	O
in	O
cell	B-Cell
growth	O
and	O
proliferation	O
>	O
protein	O
synthesis	O
>	O
gene	O
expression	O
>	O
cell	B-Cell
death	O
>	O
cell	B-Cell
cycle	O
.	O

The	O
results	O
of	O
this	O
study	O
show	O
that	O
FOXO3a	O
directs	O
an	O
anti	O
-	O
carcinogenic	O
transcription	O
program	O
that	O
culminates	O
in	O
the	O
elimination	O
of	O
carcinogen	O
-	O
damaged	O
cells	B-Cell
.	O

This	O
suggests	O
that	O
FOXO3a	O
is	O
a	O
potential	O
suppressor	O
of	O
carcinogenic	O
damage	O
in	O
LAC	B-Cancer
.	O

